CROSSPHARMA LIMITED
Get an alert when CROSSPHARMA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-04-29 (in 11mo)
Last made up 2026-04-15
Watchouts
Cash
£34K
+4.8% vs 2023
Net assets
£20M
0% vs 2023
Employees
0
Average over period
Profit before tax
£2K
-35.4% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The company has ceased trading and it is planned to wind up the company in the following year. On this basis, the directors are satisfied it is appropriate to prepare the financial statements on a non-going concern basis.
-
5 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £2,441 | £1,577 | |
| Profit before tax | £2,441 | £1,577 | |
| Net profit | £2,441 | £1,577 | |
| Cash | £32,798 | £34,375 | |
| Total assets less current liabilities | £20,245,915 | £20,247,491 | |
| Net assets | £20,245,915 | £20,247,491 | |
| Equity | £20,245,915 | £20,247,491 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 0.0% | 0.0% | |
| Current ratio | 1194.82x | 1194.91x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102 (non-going concern basis)
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The company has ceased trading and it is planned to wind up the company in the following year. On this basis, the directors are satisfied it is appropriate to prepare the financial statements on a non-going concern basis.”
Significant events
- “There have been no other significant events affecting the Company since 31 December 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 30 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ADOLPHS, Tim | Director | 2025-06-30 | May 1973 | German |
| BUSCHMANN, Daniel Bahne | Director | 2025-09-30 | Apr 1983 | German |
Show 30 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ADAMS, Geoffrey Martin | Secretary | 2015-06-29 | 2018-04-06 |
| BALLARD, Peter Gavin | Secretary | 2006-04-05 | 2007-11-28 |
| BLYTHE, Edwin Charles | Secretary | 2018-04-06 | 2021-12-13 |
| BUSCHMANN, Holger, Dr | Secretary | 2022-01-04 | 2025-06-30 |
| DÖBLER, Boris | Secretary | 2021-12-13 | 2022-01-04 |
| EREK, Cigdem | Secretary | 2025-06-30 | 2025-09-30 |
| GORE-STRACHAN, Evelyn | Secretary | 2014-06-30 | 2015-06-29 |
| HANLON, James | Secretary | 1987-07-22 | 2005-11-30 |
| HOLLAND, Richard Andrew Bruce | Secretary | 2005-11-30 | 2006-04-04 |
| WRIGHT, Philip John | Secretary | 2007-11-23 | 2014-06-30 |
| ADAMS, Geoffrey Martin | Director | 2015-06-29 | 2018-04-06 |
| ASHCROFT, Alasdair John | Director | 2008-01-01 | 2008-09-30 |
| BALLARD, Peter Gavin | Director | 2005-11-30 | 2013-10-15 |
| BLYTHE, Edwin Charles | Director | 2018-04-06 | 2021-12-13 |
| BULL, Kevan | Director | 2005-11-30 | 2007-12-31 |
| BUSCHMANN, Holger, Dr | Director | 2021-12-13 | 2025-06-30 |
| DÖBLER, Boris | Director | 2021-12-13 | 2025-06-30 |
| EREK, Cigdem | Director | 2025-06-30 | 2025-09-30 |
| FUISZ, Richard, Dr | Director | 1987-07-22 | 1999-11-12 |
| GALLAGHER, Martin Edward | Director | 2008-02-28 | 2010-05-17 |
| GORE-STRACHAN, Evelyn | Director | 2014-06-30 | 2015-06-29 |
| HANLON, James | Director | 2000-03-13 | 2021-12-13 |
| JEBLONSKI, Wolfgang | Director | 2000-03-13 | 2005-11-30 |
| MCVEY, Kenneth | Director | 1987-07-22 | 1999-06-03 |
| NIEMANN, Peter | Director | 2000-03-13 | 2005-02-28 |
| O'RIORDAN, Rory | Director | 2000-03-13 | 2008-02-28 |
| RETZLAFF, Hartmut Ulrich | Director | 2000-03-13 | 2005-11-30 |
| RUDOLPH, Dieter | Director | 2000-03-13 | 2002-06-30 |
| SCRIVENS, Patrick | Director | 1987-07-22 | 1999-11-12 |
| WRIGHT, Philip John | Director | 2007-11-23 | 2014-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Clonmel Healthcare Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-07-01 | Active |
Filing timeline
Last 20 of 165 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-03 | DISS40 | gazette | Gazette filings brought up to date | |
| 2025-12-02 | AA | accounts | Accounts with accounts type full | |
| 2025-11-25 | GAZ1 | gazette | Gazette notice compulsory | |
| 2025-10-07 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-02 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-01 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-07-17 | CH01 | officers | Change person director company with change date | |
| 2025-07-17 | CH03 | officers | Change person secretary company with change date | |
| 2025-06-30 | AP01 | officers | Appoint person director company with name date | |
| 2025-06-30 | AP01 | officers | Appoint person director company with name date | |
| 2025-06-30 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-06-30 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-06-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-27 | AA | accounts | Accounts with accounts type full | |
| 2025-01-08 | CH01 | officers | Change person director company with change date | |
| 2025-01-08 | CH01 | officers | Change person director company with change date | |
| 2025-01-07 | CH03 | officers | Change person secretary company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 15
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 5
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+4.8%
£32,798 £34,375
-
Net assets
0%
£20,245,915 £20,247,491
-
Employees
—
Not reported
-
Operating profit
-35.4%
£2,441 £1,577
-
Profit before tax
-35.4%
£2,441 £1,577
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers